Bevacizumab reduced auto-phosphorylation of VEGFR2 to protect HDM-induced asthma mice
Authors:
- 1 September 2016
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 478 (1) , 181-186
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81470228, 81270087, 81500023)
- Precision Medicine Research of the National Key Research and Development Plan of China (2016YFC0905800)
- National Program on Key Basic Research Project of China (2012CB518203)
- Natural Science Foundation of Guangdong Province (2014A030310325)
This publication has 33 references indexed in Scilit:
- Severe, but manageable hypoxia caused by bronchospasm induced by bevacizumabRespirology Case Reports, 2013
- Targeted deletion of Vegfa in adult mice induces vision lossJournal of Clinical Investigation, 2012
- VEGF receptor signaling links inflammation and tumorigenesis in colitis-associated cancerJournal of Experimental Medicine, 2010
- Epithelium: the interplay between innate and Th2 immunityImmunology & Cell Biology, 2010
- Toluene diisocyanate enhances human bronchial epithelial cells' permeability partly through the vascular endothelial growth factor pathwayClinical & Experimental Allergy, 2009
- E-cadherin controls β-catenin and NF-κB transcriptional activity in mesenchymal gene expressionJournal of Cell Science, 2008
- Expression of VEGFxxxb, the inhibitory isoforms of VEGF, in malignant melanomaBritish Journal of Cancer, 2007
- Monocyte chemoattractant protein-1–induced angiogenesis is mediated by vascular endothelial growth factor-ABlood, 2005
- IL‐1β mediated up‐regulation of HIF‐lα via an NFkB/COX‐2 pathway identifies HIF‐1 as a critical link between inflammation and oncogenesisThe FASEB Journal, 2003
- β-catenin interacts with and inhibits NF-κB in human colon and breast cancerCancer Cell, 2002